CLINICAL_TRIALS
trial_result
· 2024-10-01
Clinical Trial Update: VA as Maintenance Therapy Post Allo-HSCT in MDS and AML [Phase 2]
Summary
A Phase 2 trial evaluating VA as maintenance therapy after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Navy General Hospital, Beijing | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: NOT_YET_RECRUITING